Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Effect of kollidon® sr on the release of albuterol sulphate from matrix tablets

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: SAKR, Walid (Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia)
  • Co-author(s): El-Bagory, Ibrahim (Department of Pharmaceutics, College of Pharmacy, King Saud University, RIYADH, Saudi Arabia)
    Sakr, Adel (Department of Pharmaceutics, College of Pharmacy, King Saud University, RIYADH, Saudi Arabia)
  • Abstract:

    Albuterol sulphate, an adrenergic agonist, is an effective bronchodilator drug given orally four times daily in a dose of 2-4 mg to maintain a therapeutic blood level. Albuterol sulphate has biological half-life of about 4-6 h and thus would be a good candidate for oral extended release dosage form. The objective this study was to evaluate..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses